drugset / Trial / NCT01265056

The Effect of Neurontin on Pain Management in the Acutely Burned Patient

NCT01265056

Completed 53 enrolled Lucy A Wibbenmeyer
RandomizedParallel-groupTriple-blindTreatment

Summary

Burn patients have extreme pain. Opioids are the main agents used for analgesia. We therefore propose a single center study to fruther assess the efficacy of neuropathic agents in controlling the pain associated with acute thermal injury.

Timeline

Start
2010-02
Primary completion
2011-09
Completion
2011-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 1200 mg

Indications

No indication recorded.